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Abstract: Congenital uterine anomalies (CUA) may influence reproductive performance, resulting
in adverse pregnancy associated complications. This study aimed to assess the association of CUA
subtypes with reproductive, obstetric, and perinatal outcomes. We performed a systematic search
of the MEDLINE, EMBASE, and Cochrane libraries for studies comparing pregnancy outcomes
between women with CUA and those with a normal uterus. The random effects model was used to
estimate the odds ratios (ORs) with a 95% confidence interval (CI). Women with CUA had a lower
rate of live births (OR 0.47; 95% CI 0.33–0.69), and a higher rate of first trimester miscarriage (OR,
1.79; 95% CI 1.34–2.4), second trimester miscarriage (OR 2.92; 95% CI 1.35–6.32), preterm birth (OR
2.98; 95% CI 2.43–3.65), malpresentation (OR 9.1; 95% CI 5.88–14.08), cesarean section (OR 2.87; 95%
CI 1.56–5.26), and placental abruption (OR 3.12; 95% CI 1.58–6.18). Women with canalization defects
appear to have the poorest reproductive performance during early pregnancy. However, unification
defects were associated with obstetric and neonatal outcomes throughout the course of pregnancy. It
may be beneficial for clinicians to advise on potential complications that may be increased depending
on the type and severity of CUA.
Keywords: congenital uterine anomalies; fertility; miscarriage; obstetric outcome; neonatal outcome
1. Introduction
The prevalence of congenital uterine anomalies (CUA) varies significantly, with re-
ports ranging from 0.06 to 38% [1–8]. It can be inferred that these wide variations between
studies are due to the inaccuracy of diagnostic tests, the use of different diagnostic tech-
niques, differences in the evaluated patient population, and nonstandardized classification
systems. Moreover, in many cases of CUA, it is difficult to detect because of a lack of
awareness; therefore, the actual distribution and frequency of CUA occurrence in the
general population are not accurately known. As medical attention starts with dysfunction
(such as miscarriage or infertility), most studies have reported an increased prevalence of
CUA in patients with reproductive problems.
The female reproductive tract differentiates from two Müllerian ducts, which develop
within the first six weeks of fetal life [9,10]. Normal development of the female reproductive
tract occurs through multistep processes, such as differentiation, migration, fusion, and
subsequent absorption of the Müllerian system [11]. CUA are caused by an abnormal
interruption during this development, and may result in an inability to conceive. The
absence of a universally accepted classification system for CUA is problematic because
such a system would allow physicians to categorize the symptomatology, treatment, and
outcome in affected patients. The American Fertility Society (AFS) classification (1988) is
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the most commonly used classification, over the past three decades, for the categorization
of CUA and is also used in most of the studies. Arcuate uterus is the mildest form of
resorption failure or normal variation [12–14]. In arcuate uterus, the uterine cavity displays
a concave contour toward the fundus and is not considered clinically relevant. Depending
on the failure of organogenesis and varying degrees of fusion or absorption defects, CUA
can be divided into unification defects of the Müllerian ducts (unicornuate, bicornuate,
or didelphys uterus) and canalization defects from incomplete resorption of the midline
septum (subseptate or septate uterus) [15].
The endometrial cavity is a space for successful embryo implantation and placenta
formation, and defects in endometrial cavity formation may lead to infertility, recurrent
miscarriage, and adverse pregnancy outcomes [16,17]. CUA vary, and not all patients have
clinical symptoms. The pregnancy rate of women with CUA is not much different from that
of women with a normal uterus, and pregnancy can be well maintained and lead to normal
delivery. However, the frequency of obstetrical complications, such as miscarriage, preterm
birth, intrauterine growth restriction (IUGR), and malpresentation, is high, depending on
the type and severity of CUA [18,19]. Moreover, symptoms in CUA patients may include
nonperiodic pelvic pain, menstrual pain, abnormal vaginal bleeding, and extrauterine
pregnancies [9].
Our study aimed to evaluate the association of CUA with reproductive, obstetric, and
neonatal outcomes in women, and determine whether CUA subtypes have a specific impact
and the extent of the impact on a wide range of reproductive outcomes. To this end, the
existing literature was thoroughly reviewed, and an updated meta-analysis was performed.
2. Materials and Methods
2.1. Search Strategy
We performed a literature search for all articles published until May 2021, and written
in English, that reported comparisons of reproductive outcomes between women with CUA
and women with a normal uterus. Two reviewers (Kim MA and Kim YH) independently
performed an online systematic search using the MEDLINE, EMBASE, and Cochrane
libraries. For the search, we combined the Medical Subject Headings (MeSH) and text
terms covering CUA and reproductive outcomes. Table S1 outlines the full search strategies
for each database. The reviewers manually searched and cross referenced the review
articles found by electronic searches to locate additional cited articles that were missing
from our online searches.
2.2. Selection Criteria
The inclusion criteria for this study were as follows: studies with an appropriate
control group, and studies comparing reproductive outcomes between women with a
diagnosis of CUA and women with a normal uterus. For the pregnancy outcomes of
interest, the rate of clinical pregnancy (defined as the presence of an intrauterine gestational
sac on sonography) among the total number of women, first trimester miscarriage, second
trimester miscarriage, and recurrent pregnancy loss were investigated as reproductive
outcomes. Live births, ectopic pregnancy, preterm birth, preterm premature rupture of
membranes (PPROM), malpresentation, cesarean section, preeclampsia, placental abrup-
tion, postpartum hemorrhage, cervical incompetence, intrauterine fetal death (IUFD),
placenta previa were investigated as obstetric outcomes. IUGR or small for gestational
age (SGA; birth weight below the 10th percentile for the gestational age), low birth weight
(LBW; <2500 g), and perinatal mortality among the total number of clinical pregnancies
were investigated as neonatal outcomes. If the definition of the outcome was not specified,
the classification of authors was based on a generalized definition. Studies that met the
following criteria were excluded from the analysis: case reports and series, review articles,
studies with no or an inappropriate control group, studies where data extraction was
impossible, and studies reporting pregnancy outcomes in the same women before and after
metroplasty. We performed data extraction for each subtype of CUA.
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2.3. Study Selection
Two independent authors screened the titles and abstracts, and full articles were
selected if the study met the selection criteria and reported the reproductive outcomes
between women with CUA and those with a normal uterus. Full articles were retrieved for
clarity, unless explicitly stated in the abstract. Studies unavailable online were collected
directly from institutional libraries and references were cross checked to find additional
articles. If more than one study by the same group of investigators describing the same
population was published, the most recent version or the most comprehensive publication
was used in the final meta-analysis.
2.4. Data Extraction
We extracted the following information from each article: name of authors, journal,
study design, year of publication, country of patient, selection criteria, sample size of each
group, mode of conception, type of CUA, diagnostic technique, classification of CUA, and
data analyzed for reproductive outcomes.
2.5. Quality Assessment
We assessed the quality of the included studies using the Newcastle–Ottawa Scale
(NOS). NOS evaluates three quality parameters: selection of the study groups, compa-
rability of groups, and ascertainment of either the exposure or outcome of interest for
case-control or cohort studies, respectively. Each study had a maximum of nine points,
giving scores for various questions in each category, and those with a score of 6 or more
were considered high quality studies.
2.6. Statistical Analysis
This systematic review and meta-analysis followed the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [20] and the guidelines
provided by the Cochrane Handbook for Systematic Reviews [21]. This study was not
registered with the PROSPERO database. Reproductive outcomes were reported as odds
ratios (ORs), representing the odds of adverse reproductive outcomes for women with
CUA compared to women with a normal uterus. We used the random effects model to
calculate pooled ORs and 95% confidence intervals (CI) [22]. We performed a subanalysis
to analyze the differences in outcomes by the type of CUA. We considered I2 values > 25%,
>50%, and >75% as evidence of low, moderate, and severe statistical heterogeneity, re-
spectively. Sensitivity analysis was conducted to evaluate studies with a dominant effect
on the meta-analysis or by excluding one study each time and assessing the effect on the
main summary estimate. Statistical significance was set at p < 0.05. We performed all




The systematic search retrieved 6888 citations in total, of which 1035 were excluded as
duplicates. A total of 256 studies were considered potentially eligible for full text review by
reviewing the titles and abstracts of the remaining 5853 manuscripts. Of these 256 studies,
following the scrutiny of each manuscript, we identified 37 relevant studies [23–59] that
met the inclusion criteria as eligible for the meta-analysis (Figure 1).
The baseline characteristics of all the included studies are shown in Table 1. Of the
37 studies included, only 5 were prospective studies, whereas the remaining 32 were
retrospective studies. From these 37 studies, a total of 7053 women were identified as
having CUA and 701,527 women with a normal uterus. All studies included women with
different types of CUA. Of these 37 studies, 30 reported results for each specific subtype
of CUA, whereas seven reported the results of the entire CUA without distinction of a
particular subtype. The diagnostic methods for CUA also varied between the studies. They
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included hysterosalpingography (HSG), 2 dimensional (2D) or 3 dimensional ultrasound
(3D-US), hysteroscopy, sonohysterography, laparoscopy, laparotomy, during cesarean
section, and MRI. Each diagnostic method was used alone or in combination to confirm
the CUA. The classification system used in each study to define the subtypes of CUA was
inconsistent, but approximately half of the included studies used the classification of the
AFS. Concerning the mode of conception, 13 studies included women who underwent
assisted reproductive technologies (ART), two studies with natural conceptions (NC),
seven studies with ART/NC, and 15 studies did not mention this. The median NOS
for 37 studies was 7 (range, 6–9), and all included studies were considered high quality
(Tables S2 and S3).
Figure 1. Flow diagram of the study selection process.
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CUA, congenital uterine anomalies; 2D-US, two dimensional ultrasound; 3D-US, three dimensional ultrasound; HSG, hysterosalpingogra-
phy; TVS, transvaginal sonography, MRI, magnetic resonance imaging; IVF, in vitro fertilization; ET, embryo transfer; ICSI, intracytoplasmic
sperm injection; ART, assisted reproductive technology.
3.2. Reproductive Outcomes
3.2.1. Clinical Pregnancy Rate
Sixteen studies compared the clinical pregnancy rate in 13,478 women, consisting of
2659 women with CUA and 10,819 women with a normal uterus. When all CUA subtypes
were combined, there were no significant differences in the clinical pregnancy rate between
women with CUA and the control group (OR, 0.87; 95% CI 0.7–1.08; p = 0.2; I2 = 70%;
Figure 2A). In the subgroup analysis by CUA subtype (Table 2), pooled results in women
with an arcuate uterus showed no significant difference in clinical pregnancy rate compared
to that in women with a normal uterus (OR, 1.0; 95% CI 0.64–1.58; p = 0.99; I2 = 73%;
6 studies). In the canalization defects (OR 0.59; 95% CI 0.32–1.08; p = 0.09; I2 = 52%; seven
studies), the clinical pregnancy rate decreased significantly in septate uterus (OR 0.45;
95% CI 0.21–0.95; p = 0.04; I2 = 31%; six studies) but not in subseptate (OR 0.73; 95% CI
0.28–1.92; p = 0.53; I2 = 60%; five studies). In the unification defects (OR 0.72; 95% CI
0.57–0.9; p = 0.005; I2 = 40%; 10 studies), there were no significant differences in clinical
pregnancy rate between women with bicornuate uterus (OR 0.57; 95% CI 0.32–1.03; p = 0.06;
I2 = 3%; five studies) or didelphys uterus (OR 0.36; 95% CI 0.09–1.39; p = 0.14; I2 = 0%; three
studies) than that in women with a normal uterus. However, a meta-analysis of women
with unicornuate uterus showed a significant decrease in the clinical pregnancy rate (OR
0.75; 95% CI 0.58–0.99; p = 0.04; I2 = 59%; nine studies).
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Figure 2. Reproductive outcomes in women with congenital uterine anomalies. (A) Clinical preg-
nancy rate, (B) live birth, (C) first trimester miscarriage, (D) second trimester miscarriage.
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Table 2. Reproductive, obstetric, and neonatal outcomes according to the subtype of congenital uterine anomalies.
All CUA Arcuate Uterus
Canalization Defects Unification Defects
Subseptate Septate All Unicornuate Bicornuate Didelphys All
Clinical
pregnancy rate
0.87 (0.70, 1.08) 1.00 (0.64, 1.58) 0.73 (0.28, 1.92) 0.45 (0.21, 0.95) 0.59 (0.32, 1.08) 0.75 (0.58, 0.99) 0.57 (0.32, 1.03) 0.36 (0.09, 1.39) 0.72 (0.57, 0.90)
Live births 0.47 (0.33, 0.69) 0.45 (0.22, 0.92) 0.18 (0.02, 1.27) * 0.25 (0.09, 0.75) 0.24 (0.10, 0.57) 0.57 (0.34, 0.96) 0.61 (0.36, 1.02) 0.15 (0.01, 2.56) * 0.60 (0.40, 0.90)
First trimester
miscarriage
1.79 (1.34, 2.40) 1.38 (0.88, 2.17) 4.36 (2.64, 7.21) 2.55 (1.33, 4.91) 3.32 (1.96, 5.60) 1.45 (0.85, 2.48) 2.59 (1.25, 5.35) 1.26 (0.33, 4.76) 1.77 (1.18, 2.65)
Second trimester
miscarriage
2.92 (1.35, 6.32) 2.01 (1.03, 3.93) 1.90 (0.54, 6.75) 4.33 (2.52, 7.43) 3.38 (1.94, 5.88) 2.10 (0.95, 4.61) 2.71 (1.40, 5.23) 1.72 (0.60, 4.90) 2.28 (1.45, 3.60)
Ectopic
pregnancy
1.28 (0.81, 2.02) 0.96 (0.36, 2.57) - 1.69 (0.65, 4.40) 1.69 (0.65, 4.40) 1.61 (0.79, 3.29) 1.01 (0.22, 4.69) 3.75 (0.66, 21.39) 1.60 (0.92, 2.78)
Preterm delivery 2.98 (2.43, 3.65) 1.62 (0.86, 3.04) 3.15 (1.34, 7.40) 2.93 (2.01, 4.28) 3.11 (2.24, 4.32) 2.83 (1.92, 4.19) 3.69 (2.60, 5.22) 4.93 (3.60, 6.75) 3.50 (2.74, 4.46)
PPROM 3.50 (2.22, 5.54) - - 4.66 (1.79, 12.15) 4.66 (1.79, 12.15) 5.42 (1.80, 16.30) 3.77 (1.56, 9.08) 5.80 (1.89, 17.77) 4.66 (2.83, 7.69)
Malpresentation 9.10 (5.88, 14.08) 3.27 (1.66, 6.44) 11.42 (3.74, 34.86) 11.49 (5.24, 25.17) 11.39 (6.24, 20.78) 8.09 (3.14, 20.84) 10.87 (6.68, 17.68) 7.20 (3.09, 16.74) 8.68 (5.82, 12.95)
Cesarean section 2.87 (1.56, 5.26) 2.22 (1.07, 4.61) 5.91 (1.59, 21.95) 4.84 (2.33, 10.02) 5.02 (2.77, 9.10) 1.24 (0.76, 2.03) 5.23 (2.11, 12.96) 7.55 (2.40, 23.72) 3.91 (2.14, 7.13)
Preeclampsia 1.25 (1.07, 1.46) 0.76 (0.18, 3.22) - 0.25 (0.03, 1.82) 0.25 (0.03, 1.82) 1.27 (0.29, 5.45) 2.83 (0.29, 27.84) 0.45 (0.06, 3.31) 1.49 (0.52, 4.30)
Placental
abruption
3.12 (1.58, 6.18) 4.56 (1.03, 20.06)
17.45 (5.05, 60.22)
*
5.33 (1.50, 18.95) 9.22 (3.42, 24.82) 7.78 (1.99, 30.45) 6.53 (1.96, 21.78) 2.68 (0.51, 14.17) 6.53 (3.39, 12.61)
Placenta previa 1.56 (0.60, 4.07) 1.68 (0.22, 13.06) - 1.21 (0.16, 9.33) * 1.21 (0.16, 9.33) 2.71 (0.35, 21.28) 3.59 (1.89, 6.82) 2.18 (0.28, 17.07) 3.37 (1.88, 6.06)
Postpartum
hemorrhage
1.02 (0.67, 1.55) - - - - - - - -
Recurrent
pregnancy loss
2.61 (2.31, 2.94) - 1.65 (0.09, 32.05) * 2.69 (2.05, 3.52) 0.37 (0.02, 6.25) * 2.63 (2.01, 3.44)
Cervical
imcompetence
7.94 (3.81, 16.55) - - 9.13 (1.97, 42.33) * 9.13 (1.97, 42.33) 13.69 (2.10, 89.18) * 10.04 (6.30, 15.99) 5.49 (1.63, 18.44) 9.04 (6.11, 13.37)
IUFD 2.06 (1.36, 3.11) - - 1.04 (0.12, 9.15) 1.04 (0.12, 9.15) 2.40 (1.27, 4.53) 3.09 (0.38, 24.79) 3.30 (0.38, 28.95) 2.50 (1.39, 4.50)
IUGR or SGA 2.53 (1.77, 3.62) 3.77 (0.92, 15.46) 2.40 (1.13, 5.09) 1.90 (0.89, 4.08) 2.14 (1.26, 3.65) 3.50 (1.24, 9.91) 2.84 (1.68, 4.80) 4.03 (2.00, 8.12) 3.30 (2.29, 4.75)
Perinatal
mortality
2.17 (1.46, 3.23) 2.11 (0.79, 5.63) 2.51 (0.82, 7.69) 2.57 (1.08, 6.08) 2.55 (1.29, 5.04) 3.85 (1.61, 9.20) 3.17 (2.08, 4.84) 1.75 (0.77, 3.96) 2.93 (2.15, 4.00)
Low birth weight 1.59 (0.94, 2.68) 1.50 (0.70, 3.25) - 1.73 (0.91, 3.29) 1.73 (0.91, 3.29) 1.84 (1.08, 3.14) 1.91 (1.12, 3.27) 2.87 (1.38, 5.97) 1.99 (1.38, 2.87)
Values are given as odds ratio [95% confidence interval]. * Only one study presented data on the outcome. CUA, congenital uterine anomalies; PPROM, preterm premature rupture of membranes;
IUFD, intrauterine fetal death; IUGR, intrauterine growth restriction; SGA, small for gestational age.
J. Clin. Med. 2021, 10, 4797 14 of 23
3.2.2. Live Birth
Fifteen studies compared the rate of live births in a total of 11,113 pregnancies, com-
prising 1538 pregnancies in women with CUA and 9575 pregnancies in women with a
normal uterus. The pooled analysis showed a lower rate of live birth in women with CUA
(OR, 0.47; 95% CI, 0.33–0.69; p < 0.001; I2 = 82%; Figure 2B) than that in women with a
normal uterus. In subgroup analysis according to the subtype of CUA (Table 2), there
was a significant decrease in live birth rate in women with arcuate uterus (OR, 0.45; 95%
CI, 0.22–0.92; p = 0.03; I2 = 88%; five studies), septate uterus (OR 0.25; 95% CI 0.09–0.75;
p = 0.01; I2 = 49%; four studies), and unicornuate uterus (OR 0.57; 95% CI 0.34–0.96; p = 0.04;
I2 = 69%; 10 studies), but not in other types of CUA.
3.2.3. First Trimester Miscarriage
Thirteen studies reported data on first trimester miscarriage in a total of 81,024 preg-
nancies, which comprised 2645 pregnancies in women with CUA and 78,379 pregnancies in
women with a normal uterus. The pooled analysis showed that all women with CUA had a
higher rate of first trimester miscarriage than that in women with a normal uterus (OR 1.79;
95% CI 1.34–2.4; p <0.001; I2 = 70%; Figure 2C). Subgroup analysis according to the subtype
of CUA (Table 2) showed that the risk of first trimester miscarriage was not significantly
different between women with an arcuate uterus and those with a normal uterus (OR 1.38;
95% CI 0.88–2.17; p = 0.16; I2 = 45%; six studies). A meta-analysis of canalization defects
(OR 3.32; 95% CI 1.96–5.6; p < 0.001; I2 = 64%; six studies) revealed that subseptate uterus
(OR 4.36; 95% CI 2.64–7.21; p < 0.001; I2 = 15%; four studies) and septate uterus (OR 2.55;
95% CI 1.33–4.91; p = 0.005; I2 = 58%; five studies) had an increased risk of first trimester
miscarriage. The meta-analysis of unification defects (OR 1.77; 95% CI 1.18–2.65; p = 0.006;
I2 = 54%; eight studies) revealed that only in bicornuate uterus (OR 2.59; 95% CI 1.25–5.35;
p = 0.01; I2 = 65%; six studies) had a higher risk of first trimester miscarriage, but not in
unicornuate uterus (OR, 1.45; 95% CI, 0.85–2.48; p = 0.17; I2 = 37%; seven studies) and
didelphys uterus (OR 1.26; 95% CI 0.33–4.76; p = 0.73; I2 = 67%; four studies).
3.2.4. Second-Trimester Miscarriage
Eleven studies reported data on second trimester miscarriage in 80,347 pregnancies,
consisting of 2592 pregnancies in women with CUA and 77,755 pregnancies in women with
a normal uterus. The meta-analysis indicated that all women with CUA had a higher rate
of second trimester miscarriage than that in women with a normal uterus (OR 2.92; 95% CI
1.35–6.32; p = 0.006; I2 = 87%; Figure 2D). The subgroup analysis by type of CUA (Table 2)
showed that women with an arcuate uterus (OR 2.01; 95% CI 1.03–3.93; p = 0.04; I2 = 11%;
five studies) had a higher rate of second trimester miscarriage than that in women with
a normal uterus. In canalization defects (OR 3.38; 95% CI 1.94–5.88; p < 0.001; I2 = 18%;
five studies), second trimester miscarriage increased significantly in septate uterus (OR
4.33; 95% CI 2.52–7.43; p < 0.001; I2 = 0%; four studies), but not in subseptate uterus (OR 1.9;
95% CI 0.54–6.75; p = 0.32; I2 = 41%; three studies). In unification defects (OR 2.28; 95% CI
1.45–3.6; p < 0.001; I2 = 0%; seven studies), there were no significant differences in second
trimester miscarriage between women with unicornuate uterus (OR 2.1, 95% CI 0.95–4.61;
p = 0.07; I2 = 0%; six studies), didelphys uterus (OR 1.72; 95% CI 0.6–4.9; p = 0.31; I2 = 0%;
four studies), and women with a normal uterus. However, a meta-analysis of women with
bicornuate uterus showed a significant increase in second trimester miscarriage (OR 2.71;
95% CI 1.4–5.23; p = 0.003; I2 = 0%; five studies).
3.3. Obstetric Outcomes
3.3.1. Preterm Birth
Twenty-six studies reported the incidence of preterm birth in 702,769 pregnancies,
consisting of 6474 pregnancies in women with CUA and 696,295 pregnancies in women
with a normal uterus. The overall risk of preterm birth was significantly higher among
women with CUA (OR 2.98; 95% CI 2.43–3.65; p < 0.001; I2 = 82%; Figure 3A), except for
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the arcuate uterus (OR 1.62; 95% CI 0.86–3.04; p = 0.13; I2 = 56%; 10 studies), compared to
that in women with a normal uterus. For canalization defects (OR 3.11; 95% CI 2.24–4.32;
p < 0.001; I2 = 12%; nine studies), the pooled analysis showed a significantly higher risk of
preterm birth in the subseptate uterus (OR 3.15; 95% CI 1.34–7.4; p = 0.009; I2 = 61%; four
studies) and septate uterus (OR 2.93; 95% CI 2.01–4.28; p < 0.001; I2 = 0%; eight studies). For
unification defects (OR 3.5; 95% CI 2.74–4.46; p <0.001; I2 = 64%; 16 studies), women with
unicornuate uterus (OR 2.83, 95% CI 1.92–4.19; p < 0.001; I2 = 53%; 13 studies), bicornuate
uterus (OR 3.69; 95% CI 2.6–5.22; p < 0.001; I2 = 55%; 10 studies), and didelphys uterus (OR
4.93; 95% CI 3.6–6.75; p < 0.001; I2 = 13%; nine studies) had an increased rate of preterm
birth compared to that in women with a normal uterus (Table 2).
Figure 3. Obstetric outcomes in women with congenital uterine anomalies. (A) Preterm birth,
(B) malpresentation, (C) cesarean section, (D) placental abruption.
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3.3.2. Malpresentation
Sixteen studies reported fetal malpresentation in 690,744 pregnancies, comprising
5098 pregnancies in women with CUA and 685,646 pregnancies in women with a normal
uterus. The overall risk of malpresentation was significantly increased among women
with CUA (OR 9.1; 95% CI 5.88–14.08; p < 0.001; I2 = 97%; Figure 3B) compared to
that in women with a normal uterus. The subgroup analysis in women with arcuate
uterus (OR 3.27; 95% CI 1.66–6.44; p < 0.001; I2 = 52%; seven studies) showed a sig-
nificantly higher risk of malpresentation. In the case of canalization uterus (OR 11.39;
95% CI 6.24–20.78; p < 0.001; I2 = 81%; eight studies), subseptate uterus (OR 11.42; 95%
CI 3.74–34.86; p < 0.001; I2 = 85%; four studies), and septate uterus (OR 11.49; 95% CI
5.24–25.17; p < 0.001; I2 = 80%; eight studies) increased the risk of malpresentation com-
pared to that in women with a normal uterus. In unification defects (OR 8.68; 95% CI
5.82–12.95; p < 0.001; I2 = 91%; 10 studies), unicornuate uterus (OR 8.09; 95% CI 3.14–20.84;
p < 0.001; I2 = 78%; eight studies), bicornuate uterus (OR 10.87; 95% CI 6.68–17.68; p < 0.001;
I2 = 86%; nine studies), and didelphys uterus (OR 7.2; 95% CI 3.09–16.74; p < 0.001; I2 = 94%;
nine studies) showed a higher fetal malpresentation rate (Table 2).
3.3.3. Cesarean Section
Twenty-one studies reported data on the incidence of cesarean section in a total
of 698,716 pregnancies, which comprised 5283 pregnancies in women with CUA and
693,433 pregnancies in women with a normal uterus. A significant difference was observed
in the incidence of cesarean section among women with all CUA (OR, 2.87; 95% CI,
1.56–5.26; p < 0.001; I2 = 99%; Figure 3C), except for unicornuate uterus (OR 1.24; 95% CI
0.76–2.03; p = 0.39; I2 = 71%; nine studies), compared to that in women with a normal uterus.
The outcomes of subgroup analysis (Table 2) showed a significantly higher risk of cesarean
section in the arcuate uterus (OR 2.22; 95% CI 1.07–4.61; p = 0.03; I2 = 61%; six studies),
subseptate uterus (OR 5.91; 95% CI 1.59–21.95; p = 0.008; I2 = 87%; three studies), septate
uterus (OR 4.84; 95% CI 2.33–10.02; p < 0.001; I2 = 68%; six studies), bicornuate uterus (OR
5.23; 95% CI 2.11–12.96; p < 0.001; I2 = 95%; eight studies), and didelphys uterus (OR 7.55;
95% CI 2.4–23.72; p < 0.001; I2 = 96%; seven studies).
3.3.4. Placental Abruption
Nine studies reported data on the incidence of placental abruption in a total of
618,188 pregnancies, consisting of 3145 pregnancies in women with CUA and
615,043 pregnancies in women with a normal uterus. The overall risk of placental abruption
was significantly higher among women with CUA (OR 3.12; 95% CI, 1.58–6.18; p = 0.001;
I2 = 84%; Figure 3D) than that in women with a normal uterus. In the subgroup analysis
based on CUA subtype (Table 2), it was shown that there was a significantly higher risk of
placental abruption in the arcuate uterus (OR 4.56; 95% CI 1.03–20.06; p = 0.04; I2 = 36%;
four studies), septate uterus (OR 5.33; 95% CI 1.5–18.95; p = 0.01; I2 = 0%; three studies),
unicornuate uterus (OR 7.78; 95% CI 1.99–30.45; p = 0.003; I2 = 0%; three studies), and
bicornuate uterus (OR 6.53; 95% CI 1.96–21.78; p = 0.002; I2 = 70%; four studies), but not in
the didelphys uterus (OR 2.68; 95% CI 0.51–14.17; p = 0.24; I2 = 0%; three studies).
3.4. Neonatal Outcomes
3.4.1. Intrauterine Growth Restriction or Small for Gestational Age
Ten studies reported the incidence of IUGR or SGA in 617,231 pregnancies, consisting
of 3666 pregnancies in women with CUA and 613,565 pregnancies in women with a normal
uterus. Meta-analysis of ten studies revealed that women with CUA have an increased
risk of IUGR or SGA compared to that in women with a normal uterus (OR 2.53; 95% CI
1.77–3.62; p < 0.001; I2 = 82%; Figure 4A). In the subgroup analysis (Table 2), no significant
differences in the rates of IUGR or SGA were observed in women with arcuate uterus (OR
3.77; 95% CI 0.92–15.46; p = 0.07; I2 = 75%; five studies) and septate uterus (OR 1.9; 95%
CI 0.89–4.08; p = 0.1; I2 = 2%; five studies). The outcome of the subgroup analysis showed
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that the risk of IUGR or SGA was significantly higher in women with subseptate uterus
(OR 2.4; 95% CI 1.13–5.09; p = 0.02; I2 = 0%; three studies), unicornuate uterus (OR 3.5; 95%
CI 1.24–9.91; p = 0.02; I2 = 43%; five studies), bicornuate uterus (OR 2.84; 95% CI 1.68–4.8;
p < 0.001; I2 = 57%; six studies), and didelphys uterus (OR 4.03; 95% CI 2.0–8.12; p < 0.001;
I2 = 44%; six studies) than that in women with a normal uterus.
Figure 4. Neonatal outcomes in women with congenital uterine anomalies. (A) Intrauterine growth
restriction or small for gestational age, (B) low birth weight, (C) perinatal mortality.
3.4.2. Low Birth Weight
Nine studies reported data on the incidence of LBW in 266,765 pregnancies, consisting
of 2239 pregnancies in women with CUA and 264,526 pregnancies in women with a normal
uterus. The result for LBW was not significant (OR 1.59; 95% CI 0.94–2.68; p = 0.08; I2 = 93%;
Figure 4B) in women with CUA compared to women with a normal uterus. In the subgroup
analysis by CUA subtype (Table 2), no significant differences were found between LBW
rate in women with arcuate uterus (OR, 1.5; 95% CI 0.7–3.25; p = 0.3; I2 = 0%; two studies)
or septate uterus (OR 1.73; 95% CI 0.91–3.29; p = 0.09; I2 = 0%; two studies) and that in
women with a normal uterus. The risk of LBW was a higher in women with unification
defects (OR 1.99; 95% CI 1.38–2.87; p < 0.001; I2 = 57%; seven studies), with an OR of 1.8
in unicornuate uterus (OR 1.84; 95% CI 1.08–3.14; p = 0.02; I2 = 72%; seven studies), 1.9 in
bicornuate uterus (OR 1.91; 95% CI 1.12–3.27; p = 0.02; I2 = 0%; two studies), and 2.9 in
didelphys uterus (OR 2.87; 95% CI 1.38–5.97; p = 0.005; I2 = 0%; two studies).
3.4.3. Perinatal Mortality
Twelve studies reported data on perinatal mortality in a total of 617,278 pregnancies,
consisting of 4610 pregnancies in women with CUA and 612,668 pregnancies in women
with a normal uterus. The overall risk of perinatal mortality was higher in women with
CUA than that in women with a normal uterus (OR, 2.17; 95% CI 1.46–3.23; p < 0.001;
I2 = 48%; Figure 4C). In the subgroup analysis by CUA subtype (Table 2), no significant
differences were observed in perinatal mortality rate in women with an arcuate uterus
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(OR 2.11; 95% CI 0.79–5.63; p = 0.14; I2 = 0%; five studies), subseptate uterus (OR 2.51;
95% CI 0.82–7.69; p = 0.11; I2 = 0%; three studies), and didelphys uterus (OR 1.75; 95%
CI 0.77–3.96; p = 0.18; I2 = 0%; five studies). Conversely, women with a septate uterus
(OR 2.57; 95% CI 1.08–6.08; p = 0.03; I2 = 0%; six studies), unicornuate uterus (OR 3.85;
95% CI 1.61–9.2; p = 0.002; I2 = 42%; nine studies), and bicornuate uterus (OR 3.17; 95%
CI 2.08–4.84; p < 0.001; I2 = 0%; seven studies) showed a higher rate of perinatal mortality
than that in those with a normal uterus.
3.5. Other Outcomes
The pooled analysis showed that women with CUA had a higher rate of preeclampsia
(OR 1.25; 95% CI 1.07–1.46; p = 0.004; I2 = 0%; five studies), IUFD (OR 2.06; 95% CI 1.36–3.11;
p < 0.001; I2 = 7%; seven studies), PPROM (OR 3.5; 95% CI 2.22–5.54; p < 0.001; I2 = 26%;
three studies), recurrent pregnancy loss (OR 2.61; 95% CI 2.31–2.94; p < 0.001; I2 = 0%;
three studies), and cervical incompetence (OR 7.94; 95% CI 3.81–16.55; p < 0.001; I2 = 85%;
four studies) than that in women with a normal uterus. No significant differences in the rate
of ectopic pregnancy (OR 1.28; 95% CI 0.81–2.02; p = 0.29; I2 = 0%; 11 studies), postpartum
hemorrhage (OR 1.02; 95% CI 0.67–1.55; p = 0.93; I2 = 0%; six studies), and placenta previa
(OR 1.56; 95% CI 0.6–4.07; p = 0.36; I2 = 83%; six studies) were found between women with
CUA and those with a normal uterus. The outcomes from the subgroup analysis according
to the CUA subtype are shown in Table 2. Concerning ectopic pregnancy, preeclampsia, and
placenta previa, no significant differences were noted in the arcuate uterus and canalization
defects. In the unification defects, the rate of placenta previa was significantly higher
in women with a bicornuate uterus (OR 3.59; 95% CI 1.89–6.82; p <0.001; I2 = 0%; four
studies) than that in women with a normal uterus. Additionally, the overall risk of PPROM
(OR 4.66; 95% CI 2.83–7.69; p < 0.001; I2 = 0%; two studies), and cervical incompetence
(OR 9.04; 95% CI 6.11–13.37; p < 0.001; I2 = 0%; three studies) was increased in women
with unification defects. Likewise, women with septate uterus showed a higher rate of
PPROM (OR 4.66; 95% CI 1.79–12.15; p = 0.002; I2 = 0%; two studies) than that in women
with a normal uterus. In women with bicornuate uterus, the risk of recurrent pregnancy
loss (OR 2.69; 95% CI 2.05–3.52; p < 0.001; I2 = 0%; two studies) increased, and in women
with unicornuate uterus, the risk of IUFD (OR 2.4; 95% CI 1.27–4.53; p = 0.007; I2 = 0%;
four studies) increased.
4. Discussion
This systematic review and meta-analysis investigated the reproductive, obstetric, and
neonatal outcomes of women with CUA. This extensive and updated meta-analysis is an
attempt to review all published studies on the reproductive effects of CUA, to investigate
the association between CUA and all obstetric complications analyzed in the studies.
Based on the results of this meta-analysis, the presence of CUA has a negative impact on
most pregnancy outcomes, further supporting the theory of inadequate implantation, fetal
development, and pregnancy maintenance in CUA.
We found a significant decrease in the clinical pregnancy rate in the septate uterus and
unicornuate uterus, over threefold increased risk of miscarriage in women with canalization
defects, and a twofold increased risk in the bicornuate uterus, but this risk of miscarriage
was not found in the unicornuate and didelphys uterus. The risk of preterm birth in
women with both canalization and unification defects was over threefold higher than that
in women with a normal uterus. As gestational weeks progressed, malpresentation and,
consequently, cesarean section rates were significantly higher in all subtypes of CUA due to
a lack of uterine volume corresponding to fetal growth in the second trimester of pregnancy.
Particularly, in all subtypes of CUA, the risk of placental abruption was ninefold higher in
the canalization defects, sevenfold higher in the unification defects, and fivefold higher
even in the arcuate uterus. Additionally, we found that unification defects can be associated
with a range of obstetric and fetal complications, including LBW (twofold risk), IUGR (over
threefold risk), IUFD (2.5-fold risk), perinatal mortality (threefold risk), placenta previa
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(over threefold risk), and cervical incompetence (ninefold risk). We noted a similar risk
of PPROM has been shown in the septate uterus and unification defects, with a fivefold
increase. A septate uterus was not associated with adverse neonatal outcomes, including
LBW, IUGR or SGA, and IUFD, except for perinatal mortality (threefold risk). There were no
significant differences in preeclampsia and ectopic pregnancy between the CUA subtypes
and a normal uterus. Unlike other CUA subtypes, there was no significant difference in
most pregnancy outcomes between women with an arcuate uterus and those with a normal
uterus, except for second trimester miscarriage, placental abruption, malpresentation,
and cesarean section. An arcuate uterus, milder forms of CUA, or normal variants are
less likely to influence fertilization and early implantation processes, and impact the risk
of miscarriage. The more severe forms of CUA affect all stages of reproduction, from
fertilization to early and late pregnancy complications.
The causes and pathophysiological mechanisms of various reproductive and obstetri-
cal complications in patients with CUA remain unclear. Embryo implantation is influenced
by the vascularity and thickness of the endometrium and the morphology of the uterine
cavity [60]. The uterine septum is known to be composed of fibroelastic tissue with in-
adequate vascularization of the endometrium, which reduces endometrial receptivity to
estrogen, resulting in reduced endometrial maturation and proliferation [61,62]. Miscar-
riage can easily occur as the embryos implant on the septum because the septum with
suboptimal endometrium is morbid with reduced blood supply. Even if implantation
occurs, it does not provide a proper environment for subsequent placental and embryonic
growth. In contrast, Dabirashrafi et al. found significantly more blood vessels and muscle
tissues and less connective tissue in the septum of the uterus, which might result in poor
decidualization, placentation, and uncoordinated muscle contractility [63]. Abnormalities
of space in the uterine cavity, arrangement of uterine musculature, and impaired ability
to distend are likely to have a negative effect on pregnancy maintenance. In addition,
increased muscle mass and decreased connective tissue in the malformed cervix can cause
asymmetric uterine cavity pressure, impairing the ability of distention and growth of the
uterine cavity, which also leads to late miscarriage and preterm birth.
Currently, there is no universally accepted standard classification for CUA [11]. The
differences in sensitivity and specificity of the diagnostic tests inevitably affect the classifi-
cation and diagnosis of CUA subtypes. Therefore, classification systems and standardized
tests are essential for counseling and determining the management of CUA patients. Accu-
rate assessment of the internal and external uterine contours is critical for diagnosing and
classifying CUA. Previously, the gold standard diagnostic method was a combination of
laparoscopy and hysteroscopy. However, imaging techniques are less invasive, such as 2D-
or 3D-US, HSG, sonohysterography, and magnetic resonance imaging (MRI) for screening,
diagnosing, and classifying CUA [64]. Particularly, 2D-US and HSG are helpful in screening
for CUA, while 3D-US and MRI are suitable for categorizing CUA accurately [40,65–67].
There is still insufficient evidence on the efficacy and safety of surgical interventions
for improving reproductive performance. There is a lack of evidence on improving repro-
ductive outcomes with surgical intervention. Some reports have shown that hysteroscopic
septal division can reduce the risk of miscarriage and improve live birth rates [6,68–70],
but surgical management for incidentally diagnosed septum and fusion or unification
defects is controversial and unproven [71]. Various hysteroscopic instruments, including
microscissors, forceps, operating loop, electrosurgical needle, and laser energy, have been
proposed for surgical correction [72]. Gradually, several methods are being introduced to
help the proliferation of endometrial tissue, reduce adhesion formation and minimize in-
traoperative or postoperative complications [73]. Tissue vaporization and coagulation with
low power diode laser energy can rapidly remove the uterine septum without damaging
the underlying myometrium [74,75]. Still, there is a lack of large scale studies on which
technique is better.
Chan et al. [18] previously reported the correlation between CUA and representative
pregnancy outcomes, such as miscarriage, preterm birth, and malpresentation, by meta-
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analyzing nine studies. Venetis et al. [19] analyzed the pregnancy outcomes in women
with CUA by adding LBW, IUGR, PPROM, placental abruption, and perinatal mortality
extracted from 24 studies. We conducted an extensive and updated meta-analysis to
evaluate the association between the different types of CUA and various reproductive,
obstetric, and neonatal outcomes, in 37 studies where a more comprehensive assessment of
the evidence was available. Undoubtedly, the negative impacts of CUA on pregnancy begin
in the early stages of fertilization and the impacts span the entire reproductive process.
However, the lack of data on individual CUA subtypes makes it difficult to draw clear
conclusions about the exact subtype specific effects on complications and their underlying
mechanisms. Although most women with CUA experience a normal reproductive outcome,
it is necessary to advise on the risks that may be increased depending on the type and
severity of CUA.
To fully investigate the effects of CUA on obstetric and fetal complications, collecting
all published studies and conducting a thorough and conclusive meta-analysis may be
hampered by the heterogeneity of the currently available studies. This meta-analysis
was confounded by the heterogeneity of the included clinical studies. The use of several
diagnostic methods with variable accuracies, the absence of a universal classification
system, discrepancies in interpretation of CUA classification, and the heterogeneity of
study populations have all contributed to a difficulty in deriving the study results. As we
collected and analyzed studies published over the past half century, there are inevitable
differences in study population characteristics, diagnostic methods, classification system
of CUA, and definition of outcome. Most of the included studies have a retrospective
design, and various confounding variables, such as age, body mass index, hormonal status,
and socioeconomic status, that can introduce bias. Therefore, future studies should be
conducted through well designed prospective observational studies that consider these
potential confounding factors to establish more detailed evidence of the risk of adverse
reproductive outcomes in women with CUA.
This study showed that all subtypes of CUA have an increased risk of second trimester
miscarriage, preterm birth, placental abruption, fetal malpresentation, and cesarean section.
It was found that women with canalization defects seem to have the poorest reproductive
performance in early pregnancy. In unification defects, only the unicornuate uterus is
shown to reduce fertility, and bicornuate uterus increases miscarriage, while didelphys
uterus is not associated with risk of fertility and miscarriage. However, unification defects
were primarily associated with obstetric and neonatal outcomes throughout pregnancy.
The abnormal uterine environment disrupts fertilization, implantation, and later pregnancy
and birth outcomes. In conclusion, women with CUA can develop adverse reproductive,
obstetric, and neonatal outcomes according to CUA subtypes. The uterus is an essential
organ in which critical phenomena of the reproductive process occur, including sperm
migration, embryo implantation, fetal development and growth, and, finally, the induction
of labor and childbirth. CUA can influence these uterine functions and prevent success-
ful pregnancies. It may be beneficial for clinicians to care for women with CUA and
inform them about potential complications and treatment options through evidence based
counseling and an accurate diagnosis before and during pregnancy.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/jcm10214797/s1, Table S1: Search strategies; Table S2: Study Quality Assessment for Cohort
studies (Newcastle–Ottawa Scale); Table S3: Study Quality Assessment for Case–Control Studies
(Newcastle–Ottawa Scale).
Author Contributions: M.-A.K. and Y.-H.K.: the conception and design of the study; acquisition
of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the
manuscript; H.S.K.: analysis and interpretation of data; M.-A.K., H.S.K. and Y.-H.K.: critical revision
of the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding: This research was supported by a faculty research grant of Yonsei University College of
Medicine (6-2013-0183).
J. Clin. Med. 2021, 10, 4797 21 of 23
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: The data presented in this study are available on request from the
corresponding author.
Conflicts of Interest: All authors declare that they have no conflict of interest.
References
1. Simón, C.; Martinez, L.; Pardo, F.; Tortajada, M.; Pellicer, A. Müllerian defects in women with normal reproductive outcome.
Fertil. Steril. 1991, 56, 1192–1193. [CrossRef]
2. Makino, T.; Hara, T.; Oka, C.; Toyoshima, K.; Sugi, T.; Iwasaki, K.; Umeuchi, M.; Iizuka, R. Survey of 1120 Japanese women with a
history of recurrent spontaneous abortions. Eur. J. Obstet. Gynecol. Reprod. Biol. 1992, 44, 123–130. [CrossRef]
3. Makino, T.; Umeuchi, M.; Nakada, K.I.; Nozawa, S.; Iizuka, R. Incidence of congenital uterine anomalies in repeated reproductive
wastage and prognosis for pregnancy after metroplasty. Int. J. Fertil. 1992, 37, 167–170. [PubMed]
4. Clifford, K.; Rai, R.; Watson, H.; Regan, L. An informative protocol for the investigation of recurrent miscarriage: Preliminary
experience of 500 consecutive cases. Hum. Reprod. 1994, 9, 1328–1332. [CrossRef] [PubMed]
5. Acién, P. Incidence of mullerian defects in fertile and infertile women. Hum. Reprod. 1997, 12, 1372–1376. [CrossRef]
6. Homer, H.A.; Li, T.C.; Cooke, I.D. The septate uterus: A review of management and reproductive outcome. Fertil. Steril.
2000, 73, 1–14. [CrossRef]
7. Guimarães Filho, H.A.; Mattar, R.; Pires, C.R.; Araujo Júnior, E.; Moron, A.F.; Nardozza, L.M. Prevalence of uterine defects in
habitual abortion patients attended on at a university health service in brazil. Arch. Gynecol. Obstet. 2006, 274, 345–348. [CrossRef]
8. Guimarães Filho, H.A.; Mattar, R.; Pires, C.R.; Araujo Júnior, E.; Moron, A.F.; Nardozza, L.M. Comparison of hysterosalpingogra-
phy, hysterosonography and hysteroscopy in evaluation of the uterine cavity in patients with recurrent pregnancy losses. Arch.
Gynecol. Obstet. 2006, 274, 284–288. [CrossRef]
9. Lin, P.C.; Bhatnagar, K.P.; Nettleton, G.S.; Nakajima, S.T. Female genital anomalies affecting reproduction. Fertil. Steril.
2002, 78, 899–915. [CrossRef]
10. Motta, P.M.; Nottola, S.A.; Makabe, S. Natural history of the female germ cell from its origin to full maturation through prenatal
ovarian development. Eur. J. Obstet. Gynecol. Reprod. Biol. 1997, 75, 5–10. [CrossRef]
11. Rackow, B.W.; Arici, A. Reproductive performance of women with müllerian anomalies. Curr. Opin. Obstet. Gynecol.
2007, 19, 229–237. [CrossRef]
12. Buttram, V.C., Jr.; Gomel, V.; Siegler, A.; DeCherney, A.; Gibbons, W.; March, C. The american fertility society classifications of
adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, müllerian anomalies and
intrauterine adhesions. Fertil. Steril. 1988, 49, 944–955.
13. Salim, R.; Regan, L.; Woelfer, B.; Backos, M.; Jurkovic, D. A comparative study of the morphology of congenital uterine anomalies
in women with and without a history of recurrent first trimester miscarriage. Hum. Reprod. 2003, 18, 162–166. [CrossRef]
[PubMed]
14. Heinonen, P.K.; Saarikoski, S.; Pystynen, P. Reproductive performance of women with uterine anomalies. An evaluation of
182 cases. Acta Obstet. Gynecol. Scand. 1982, 61, 157–162. [CrossRef] [PubMed]
15. Chandler, T.M.; Machan, L.S.; Cooperberg, P.L.; Harris, A.C.; Chang, S.D. Mullerian duct anomalies: From diagnosis to
intervention. Br. J. Radiol. 2009, 82, 1034–1042. [CrossRef] [PubMed]
16. Kupesic, S. Clinical implications of sonographic detection of uterine anomalies for reproductive outcome. Ultrasound Obstet.
Gynecol. 2001, 18, 387–400. [CrossRef]
17. Kupesic, S.; Kurjak, A. Diagnosis and treatment outcome of the septate uterus. Croat. Med. J. 1998, 39, 185–190.
18. Chan, Y.Y.; Jayaprakasan, K.; Tan, A.; Thornton, J.G.; Coomarasamy, A.; Raine-Fenning, N.J. Reproductive outcomes in women
with congenital uterine anomalies: A systematic review. Ultrasound Obstet. Gynecol. 2011, 38, 371–382. [CrossRef]
19. Venetis, C.A.; Papadopoulos, S.P.; Campo, R.; Gordts, S.; Tarlatzis, B.C.; Grimbizis, G.F. Clinical implications of congenital uterine
anomalies: A meta-analysis of comparative studies. Reprod. Biomed. Online 2014, 29, 665–683. [CrossRef]
20. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Reprint–preferred reporting items for systematic reviews and meta-analyses:
The prisma statement. Phys. Ther. 2009, 89, 873–880. [CrossRef]
21. Davey, J.; Turner, R.M.; Clarke, M.J.; Higgins, J.P. Characteristics of meta-analyses and their component studies in the cochrane
database of systematic reviews: A cross-sectional, descriptive analysis. BMC Med. Res. Methodol. 2011, 11, 160. [CrossRef]
[PubMed]
22. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7, 177–188. [CrossRef]
23. Zhang, L.; Wang, X. Clinical outcomes analysis of infertile women with unicornuate uterus in ivf-et. J. Gynecol. Obstet. Hum.
Reprod. 2021, 50, 102111. [CrossRef]
24. Zambrotta, E.; Di Gregorio, L.M.; Di Guardo, F.; Agliozzo, R.; Maugeri, G.C.; Gulino, F.A.; Cutello, S.; Cerana, M.C.; Palumbo, M.
Congenital uterine anomalies and perinatal outcomes: A retrospective single-center cohort study. Clin. Exp. Obstet. Gynecol.
2021, 48, 161–164.
J. Clin. Med. 2021, 10, 4797 22 of 23
25. Kong, W.Y.; Zhao, S.R.; Deng, K.; Zhang, Q.; Liu, W.; Yan, L. Effects of bicornuate uterus on pregnancy and obstetric outcomes
of in vitro fertilization / intracytoplasmic sperm injection. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021, 258, 132–138. [CrossRef]
[PubMed]
26. Ouyang, Y.; Cai, P.; Gong, F.; Lin, G.; Qin, J.; Li, X. The risk of twin pregnancies should be minimized in patients with a unicornuate
uterus undergoing ivf-et. Sci. Rep. 2020, 10, 5571. [CrossRef] [PubMed]
27. Neal, S.A.; Morin, S.J.; Werner, M.D.; Gueye, N.A.; Pirtea, P.; Scott, R.T., Jr.; Goodman, L.R. Three-dimensional ultrasound
diagnosis of t-shaped uterus is associated with adverse pregnancy outcomes after embryo transfer. Reprod. Biomed. Online
2019, 39, 777–783. [CrossRef]
28. Chen, X.; Liu, P.; Sheng, Y.; Li, W.; Tang, R.; Ding, L.; Qin, Y.; Chen, Z.J. The impact of unicornuate uterus on perinatal outcomes
after ivf/icsi cycles: A matched retrospective cohort study. J. Matern. Fetal Neonatal Med. 2019, 32, 2469–2474. [CrossRef]
29. Cahen-Peretz, A.; Sheiner, E.; Friger, M.; Walfisch, A. The association between müllerian anomalies and perinatal outcome.
J. Matern. Fetal Neonatal Med. 2019, 32, 51–57. [CrossRef]
30. Prior, M.; Richardson, A.; Asif, S.; Polanski, L.; Parris-Larkin, M.; Chandler, J.; Fogg, L.; Jassal, P.; Thornton, J.G.; Raine-Fenning,
N.J. Outcome of assisted reproduction in women with congenital uterine anomalies: A prospective observational study. Ultrasound
Obstet. Gynecol. 2018, 51, 110–117. [CrossRef]
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